ENDODAN (STAT RX USA LLC)
Welcome to the PulseAid listing for the ENDODAN drug offered from STAT RX USA LLC. This Full Opioid Agonists [MoA],Opioid Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | STAT RX USA LLC |
NON-PROPRIETARY NAME: | OXYCODONE and ASPIRIN |
SUBSTANCE NAME: | OXYCODONE HYDROCHLORIDE; ASPIRIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
START MARKETING DATE: | 1994-05-20 |
END MARKETING DATE: | 0000-00-00 |
ENDODAN HUMAN PRESCRIPTION DRUG Details:
Item Description | ENDODAN from STAT RX USA LLC |
LABELER NAME: | STAT RX USA LLC |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 4.8355; 325(mg/1; mg/1) |
START MARKETING DATE: | 1994-05-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16590-947_4f2f4e43-bf7a-498a-9367-e0bdaf0cf8da |
PRODUCT NDC: | 16590-947 |
APPLICATION NUMBER: | NDA007337 |
Other OXYCODONE HYDROCHLORIDE; ASPIRIN Pharmaceutical Manufacturers / Labelers: